NCT01149434: Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers |
|
|
| Terminated | 1/2 | 19 | US | JI-101, Everolimus, RAD001 | University of Utah, Jubilant Innovation Ltd. | Cancer, Neuroendocrine, Ovarian Cancer, Colon Cancer | 08/12 | 08/12 | | |
